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Abstract
MicroRNAs are positive and negative regulators of eukaryotic gene expression that modulate transcript
abundance by specific binding to sequence motifs located prevalently in the 3′ untranslated regions of
target messenger RNAs (mRNA). Interferon-alpha-2a (IFNα) induces a large set of protein coding genes
mediating antiproliferative and antiviral responses. Here we use a global microarray-based microRNA
detection platform to identify genes that are induced by IFNα in hepatoma- or melanoma-derived human
tumor cell lines. Despite the enormous differences in expression levels between these models, we were
able to identify microRNAs that are upregulated by IFNα in both lines suggesting the possibility that
interferon-regulated microRNAs are involved in the transcriptional repression of mRNA relevant to
cytokine responses.
Key words: MicroRNAs, Oligonucleotide Array Sequence Analysis, Interferons, Melanoma, Hepato-
ma, Reverse Transcriptase Polymerase Chain Reaction, Suppressor of Cytokine Signaling Proteins.
1. Introduction
The gene expression patterns of tumor-derived cell lines differ greatly,
as do their responses to antiproliferative effects of interferons (IFNs).
The cause of this variation has been under investigation formore than
40 years, but only basic regulatorymechanisms of interferon signal-
ing are understood today. Small regulatory genome encoded
RNAs, such as microRNAs, have recently attracted attention in
genomic research. New methods to analyze the levels of these
regulatory elements are now commercially available, but the power
of these techniques is still discussed extensively. Our study was
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designed to compare two methods for microRNA detection with
respect to usefulness in defined cell culture assays. The experimental
design assesses variation between the two cell lines and the treatment
effects of IFNα.
A hallmark of the therapeutic activity of type I interferons is the
induction of antiproliferative activity mediated by the upregulation
of several hundred response genes with pleiotropic functions (1).
These genes can be divided into two major classes based on the
kinetic properties of induction (2). Primary response genes (PRGs)
are upregulated within 24 h after the cytokine signal and the
secondary response genes (SRGs) are induced following day1
when the activity of the PRGs decays. In contrast to SRGs,
all PRGs studied to date contain bona fide interferon response
elements in the promoter region, which are required for binding of
the interferon-stimulated gene factor 3 (ISGF3) complex and for
janus kinase/signal transducer of transcription (JAK/STAT)-
pathway-mediated signaling.
Expression of PRGs is turned off by proteins termed suppressors
of cytokine signaling (SOCS) (3). As the nomenclature indicates,
this class of polypeptides has the capacity to interfere and silence
other cytokine-induced signaling cascades (for review see (4)).
SOCS1 for instance is part of the early inducible PRG cluster and
downmodulation occurs together with the other genes before onset
of SRG expression. It is believed that feedback inhibition of JAK/
STAT signaling by SOCS1 represses transcriptome modulation
of IFNα signaling (5). Regulation of SOCS protein translation
by interferon-regulated microRNAs (IRmiRs) would enhance
the potential of cytokine fine regulation. It has been reported that
miR-19 antagonists lead to higher SOCS1 levels and miR-19
mimics can repress SOCS1 reporter constructs, thus obviously
supporting the bioinformatic predictions that SOCS1 is a direct
target of miR-19 (6). Inhibition of SOCS activity could for
instance prolong the duration of cytokine activity, which has
obvious clinical implications.
Following the discovery of microRNAs in virtually all higher
eukaryotic organisms significant research efforts were initiated to
address the function of these catalytic oligonucleotides which are
the natural counterparts of synthetic small inhibitory RNAs (siRNAs)
used for experimental gene silencing (for review see (7)).MicroRNAs
are positive and negative modulators of the expression of entire gene
clusters that contain complementary microRNA recognition
sequence motifs in the 3′-UTR. Today, prediction of microRNA
target genes by homology-based algorithms is still ambiguous (8).
The activity of one or several microRNAs could explain suppression
of the entire PRG cluster provided that microRNA abundance is
regulated by IFNα. Alternatively, microRNA-mediated degradation
of transcripts encoding negative regulatory proteins would also
abolish PRG expression and restore IFNα responsiveness.
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Some recent reports showed that interferon beta (IFNβ)
stimulation can boost microRNA levels in cell culture together
with inhibition of viral replication (9). At this point it is an
open question whether this induction is IFNβ specific or a
shared feature of all type I interferons. To investigate whether
microRNA are also involved in regulation of IFNα response, we
used two human-tumor-derived cell lines: the melanoma line
ME-15 (10) and the hepatoma line HuH7 (11). We have
chosen these cell lines as models, because we have a good
understanding of the IFNα responses at the mRNA and the
protein levels in these cell lines. Further we chose to use a
melanoma cell line because IFN is also used for treatment of
this cancer type. HuH7 is commonly used as a model for testing
antiviral effects of IFN in the HCV replicon system. In both
models efficient responses to IFNα have been shown at the
functional and transcriptional level. IFNα response genes carry
response elements in their promoter region and these motifs are
responsible for gene expression with similar efficiency in many cell
types. Therefore we expected to find a similar regulated set of genes
in both lines given that IRmiR genes are regulated by the same
mechanism, whereas some constitutively expressed microRNA
genes were expected to be cell type specific for functional reasons.
We have chosen a DNA-microarray-based technology (Illumina)
for the multi-parallel expression analysis of all known human
microRNAs (http://microrna.sanger.ac.uk/; Release 10.0: August
2007). This method allowed us to process total RNA as
template, allowing the possibility of mRNA gene expression
profiling in further experiments. Briefly, annealing of microRNA
specific primers combined with enzymatic polyadenylation
allows multi-parallel polymerase chain reaction (PCR)-mediated
amplification of individual microRNAs. The output of this step is a
DNA amplicon library that reflects to a large extent the original
stoichiometry of mature microRNAs in a cell or tissue (12). PCR
amplification is performed with fluorescently labeled primers, which







Melanoma cells (ME-15) were cultured in RPMI 1640 with
L-Glutamine supplemented with non-essential amino acids and
sodium pyruvate (1 mM) and hepatoma (HuH7) cells were
cultured in DMEM + GlutaMAX. Both media contained 10%
FBS. All cell culture reagents were purchased from Invitrogen
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(GIBCO®). Roferon (Interferon alpha2a, ROCHE) was diluted in
fresh medium to a final concentration of 1,000 U/mL and control
cultures were grown without cytokine. Cells were cultured at
37°C in a humidified atmosphere containing 5% CO2. Total RNA
preparation was carried out using TRIZOL (Invitrogen) total
RNA extraction using 1/2 volume of 1-bromo-3-chloro-propane
(molecular biology grade, SIGMA) as chloroform substitute. For
efficient recovery of small RNAs, DNA LoBind tubes (Eppendorf)
were used and all centrifugation steps were performed at maximum
speed and 4°C in an Eppendorf 5417R centrifuge. Total RNA was
precipitated with 2 vol of 2-propanol (Fluka) at −20°C for at least
16 h. The RNA pellet was washed with 75% ethanol (Merck), dried,
and dissolved in DEPC-treated water (Ambion). The RNA was
quantified with Quant-iT™ RiboGreen® RNA Assay (Invitrogen)




Starting with 500 ng/sample of total RNA, mature microRNAs
were amplified with the Illumina human v1 MicroRNA expression
profiling kit containing primers for 743 human microRNAs. The
resulting amplicons were hybridized to a 96 sample universal
probe capture array and fluorescent signals were detected by





Thedatawas processedwithBeadstudio software (version 3.1.3, gene
expression module 3.3.8) including the calculation of detection
p values based on negative control bead signals. Log-transformation,
loess normalization (13) and statistical analysis were performed with
R (2.8.1) (14) using the package lumi (1.8.3) (15) and software
contained therein, in particular limma (2.16.4) (16). Statistical
models were chosen as follows: a linearmodel (limma t statistics) with
two separate coefficients for HuH7 andME-15 cells was used for the
selection of differently expressed genes shown in Fig. 1 and Table 1.
Statistics represented in the tables were calculated by testing the two
indicated conditions as independent factors. In Table 1, p values were
adjusted by the false discovery rate method (17). Treatment effects
shown in Table 2b and Fig. 3a were modeled with two coefficients
(cell line, treatment) for time point 4 h, p values arise from t statistics.
Normalized relative fluorescence levels were calculated by 2^mean
(of log2 transformed, loess normalized values). Change factors
(CHF) were calculated as fold change on the linear scale minus 1 as
previously described (2). Raw data, non-normalized, and normalized
microRNA expression data have been submitted to the Gene Expres-
sion Omnibus with accession number GSE16421.
2.4. Quantitative PCR
and Data Processing
microRNA levels were measured using TaqMan®microRNA assays
(Applied Biosystems) using the TaqMan® MicroRNA reverse
transcription (RT) kit with TaqMan® 2× universal PCR master
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mix (No AmpErase® UNG) as recommended by the supplier. Ten
nanograms of total RNA was used as input for amplification using
the samples used for microarray analysis. Reversed transcriptase
products were diluted 1:15 and measured on an ABI 7900HT fast
real-time PCR system. Technical replicates were run on three
different plates (one with 40 cycles and two with 50 cycles) and
threshold for cycling time (CT) calculation was set for all probes
to 0.2. For estimation of endogenous small RNA content, the
nucleolar RNA RNU48 was used as control and reference.
Fig. 1. Differential microRNA expression in human melanoma (ME-15)
and hepatoma (HuH7) cells. microRNA expression levels were compared
in two cell lines at two different time points and corrected for the treat-
ment effect. The 50 most significant (p value below 10−¹²) microRNA ex-
pression values from untreated samples are shown in a heat diagram
including hybridization controls as reference for technical variance. White
indicates noise levels, yellow indicates the first quartile, orange the median,
red the third quartile, and black maximum expression levels. The intensity
data, significance values and the IFNα-dependent expression levels are
summarized in Table 1.
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Standard error (Δx) was calculated by the average standard
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3. Results
and Discussion
The following technical aspects have to be considered for result
interpretation. The dataset of the microRNA bead array assay is
not directly comparable to gene expression arrays where in vitro
translated transcripts are directly hybridized to the probes.Moreover
Illumina’s bead array technology tends to have higher background
fluorescence levels and lower change factor values than Genechips
from Affymetrix. Background (average of negative control signals)
and noise (standard deviation of negative probes from each sample)
were 528±60 and 229±67, respectively. The density of all samples
shows a bimodal distribution peaking around the background
fluorescent levels and the robust levels (approximately 12,000).
The curve is skewed to the right and peak density height is found
in the ratio 4:1 considering all probes (data not shown). The
distribution of probes detected in all samples (detection p value
Fig. 2. Cell line specific microRNA expression Volcano plot (a) display demonstrates the multi-variant
biological diversity of microRNA expression in ME-15 or HuH7 cells. The estimated fold-change
value (change factor) is plotted on the X-axis against the p value (limma t statistics) in logarithmic
scale on the Y-axis. A linear model, using the expression values of untreated ME-15 cells at 4 h
as base together with three parameters to estimate differences in time, treatment, or cell line. The top
ranked and qPCRmeasuredmicroRNAs are annotated. bQuantitative PCRvalidation ofmicroarray data
using eight selected microRNAs. Input total RNA came from independent cell cultures. Data are shown
as relative cycling times (ΔCT) calculatedwith endogenous control RNU18 forME-15 (color-filled bars) and
HuH7 (gray). Error bars represent ΔCT±Δx (standard deviation of biological replicates). ΔΔCT are noted
above the bars together with the significance codes for t statistics defined by the intervals ‘***’ G 0.001
≤ ‘**’ G 0.01 ≤ ‘*’ G 0.05 ≤ ‘.’ G 0.1.
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threshold at 0.01) has a plateau ranging from about 2,000 close to
the detectors maximum capacity of 2^16 relative fluorescent units
(12). As expected, the correlation of data coming from biological
replicates r²=0.952±0.028 (not normalized) and r²=0.956±0.022
(after loess normalization and log-transformation) was lower than
for technical replicates r²>0.97 (12). We preferred loess normaliza-
tion to quantile normalization because the later was too aggressive
for the given small probe numbers.
As a first step we wished to address the robustness of the micro-
RNA array in probe detection by selectingmicroRNA genes that are
detected under all experimental conditions with high statistical
significance in all biological triplicates (detection p valueG0.01). In
each set of triplicate samples (control, 4 h or 24 h, IFNα stimulation)
we detect approximately 270 genes that fulfill the above criteria. This
corresponds to roughly a third of microRNAs available for detection
in the assay system. Furthermore, this result suggests indirectly that
IFNα treatment does not induce global changes in microRNA gene
expression, but it modulates rather the expression of individual
genes.
Fig. 3. IFNα-dependent modulation of microRNA expression. a Volcano plot display of IFNα induced
microRNA upregulation 4 h after induction. The change factor values (2^log factor change −1) are
plotted on the X-axis against the p value in logarithmic scale on the Y-axis. Top-rated microRNAs
are annotated together with the let-7 family members. b Confirmation of IFNα effect for selected
microarray data by qPCR. The CT-values are the average of three technical and three biological
replicates and changes were calculated with 2^ΔMNE (mean normalized expression values). Error
bars show 2^ΔMNE±Δx (average standard error of treated and untreated MNE) from biological
triplicates. miR-30e failed to amplify in ME-15 and miR-203 was below the detection limit in
HuH7. Expression values were normalized against endogenous snoRNA RNU48 levels.
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Today it is well established that microRNA expression
patterns are cell and tissue type specific, which is consistent with
a role in cell differentiation and biological function (8). Thus
we expected to detect genes with preferential expression in either
hepatoma or melanoma cells as these cell lines are derived from
different tumors. Indeed, when all experimental conditions and
data points are included in the data analysis about 150 micro-
RNAs genes show preferential expression in either HuH7 or
ME-15 cells (Fig. 1). Table 1 shows the expression data for the
most significant genes including change factors and significance
score as reference. Among these differentially expressed genes
there are three members of the let-7 family, which has properties
of tumor suppressor genes (for review see (18)). Therefore it is not
surprising that the members of this well-known microRNA gene
family are deregulated in the analyzed cancer cells too. Further-
more, the different developmental stage of our cancer cell lines
is expected to have left a genomic fingerprint where some micro-
RNA genes are expressed in one but not the other cell line (19).
Consistent with this, expression of some microRNAs is strictly cell
type specific and barely detectable in the other cell type (Fig. 2a),
for example the liver-specific miR-122a and miR-192 (20).
Bead-array-based microRNA detection technology, including
the bio-statistic analysis, is currently not well established or widely
used and we have applied a commercial PCR-based assay to con-
firm the array data for some microRNAs that cover different ex-
pression levels and change factors. In contrast to mRNA
profiling, where RT-PCR-based assays are considered as gold
standard for data validation, new generation deep sequencing is
considered as the method of choice for microRNA quantification
but is not available in our research institute. For the microRNAs
let-7 a/b, miR-19 a/b, and miR-203, the PCR-based quantifica-
tion method (Fig. 2b) confirmed the direction of change found
with microarray technology (Table 2a). Expression of miR-130b
and miR-455 was at similar levels in both assays. The correla-
tion calculated for the eight tested microRNAs was acceptable:
multiple r² from f test of mean relative cycling times (ΔCT) to
mean log2 microarray expression values was 0.9279. Differences of
absolute levels between themicroRNA targets probably results from
different hybridization properties of the microarray probes and
variation in the performance of Taqman primers for the specific
microRNA on the other side.
Assuming that any IFNα relevant microRNA will have the
same kinetics as the mRNA for PRGs, we looked at the regulation
of microRNA genes in our experiment. These IRmiRs should
respond to IFNα stimulation preferentially in both cell lines,
because this would be a good indication of a general mechanism
in the IFNα response. Within the 25 most significantly regulated
genes (Table 2b), only one gene (HS_250) is downregulated. A
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general upregulation of transcripts is consistent with classic IFNα
signaling seen for mRNAs. However, the maximal observed
change factor with high significance was 1.84 (miR-33b in
Table 2b) which is clearly lower than the values seen for protein
coding mRNAs (2). We also included an expression analysis 24 h
after IFNα stimulation in order to detectmicroRNAgenes that show
either delayed induction or remain activated at comparable levels to
the 4 h stimulus. Based on our data set, the majority of the
microRNA response genes show no further induction, but rather
moderate downregulation 24 h after induction. This finding is not
surprising as we expected immediate early impact of IFNα-mediated
primary signaling.
We also measured the IFNα response in the same experiment
and for the same microRNAs (Table 2c). When we analyze the
IFNα effect at the early time point in both cell lines we find all
the validated microRNAs to be upregulated (Fig. 3a). The
magnitude of upregulation and the basal expression levels of the
microRNA-19a and 19b are similar in both cell lines (Fig. 3b,
top). This and the finding that miR-19 regulates SOCS1 (4)
may be relevant for the regulation of cytokine signaling. let-7a
and let-7b had higher levels in the melanoma-cell-line-derived
samples compared HuH7, but the induction by IFNα in
ME-15 could not be reproduced by RT-PCR (Fig. 3b, bottom). In
both assays accurate fold changes are difficult to calculate, if the
baseline expression level is close to background noise or the detection
limit. An example of a gene at the detection limit is miR-203, which is
not detectable without IFNα treatment in HuH7 cells (Table 2c).
Upon IFNα stimulation (24 h inHuH7) themicroRNA is detectable
above background suggesting minimal induction. Consequently a
solid change factor cannot be calculated, which is consistent with
the high variance obtained by qPCR (ME-15). This result is in fact
not surprising, because both technologies rely on logarithmic PCR
amplification of microRNA templates. At low expression levels, both
technologies show relatively high variation in biological replicates,
which should be considered for data interpretation. Interestingly,
miR-203 has a putative binding site for ISGF3 in the promoter
region, which would enable IFNα-dependent upregulation.
miR-30 has been reported to be IFNβ inducible, although the
subclass measured was not specified by the authors (9). We decided
to analyze the most promising candidate (miR-30e-5p) present in
our microarray dataset (Fig. 3a in gray). Detection of miR-30e failed
in ME-15 cells due to technical problems, but induction in HuH7
was similar to miR-19a/b.
Some technology-related questions remain open. The micro-
RNA assay measures essentially the number of amplicons generated
by RT-PCR for each transcript. Thus the signal is an indirect
measurement of transcript abundance as compared to classical
mRNA microarray platforms, where the target mRNA is directly
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labeled during linear amplification by in vitro transcription. As a
consequence, change factor calculations for amplicon-based assays
are ambiguous.
In summary, Illumina’s bead array technology is well suited for
multi-parallel profiling of microRNAs expressed in different cell
types or tissues. We were also able to detect IFNα-inducible
microRNA genes although the changes observed were moderate and
biological significance remains to be proven. Like most microarray-
based detection technologies the technical variability among
identical samples is low compared to biological variations of
individual cell cultures. At this point it is important to note
that variation among biological samples occurs and is independent
of the parameters that are measured. Consistent with IFNα-
dependent induction of mRNAs we find that virtually all modulated
microRNA genes are upregulated. However, the IFNα-induced
changes detected in our study are relatively small compared to the
changes induced by IFNβ inHuH7 cells (9). Finally, it is noteworthy
that IRmiRs have similar kinetic properties to their mRNA counter-
parts. miR-10b for instance is induced early in ME-15 and remains
upregulated, while miR-19 abundance ceases after 24 h. In general,
the majority of IRmiR genes were reset to basal levels after 24 h and
further studies are needed for kinetic classification. Thus, our study
adds another level of complexity to the dynamic regulation IFNα
signaling and other mechanisms like epigenetic promoter methyla-
tion are currently under intense investigation in our laboratories.
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